Andrx Changes CEOs
This article was originally published in The Pink Sheet Daily
Former Chesapeake Biological Laboratories President Thomas Rice is taking over as CEO of Andrx, effective immediately, the company announced Feb. 3
You may also be interested in...
Andrx is not for sale despite a change in top-level management, new CEO Thomas Rice says
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.